KYMR
Kymera Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -0.9% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +12 | 52.72M | $6.01B | +14 | −1 |
| Q1 2026 | 91 | -4 | 48.20M | $4.01B | +6 | −11 |
| Q4 2025 | 94 | 0 | 48.74M | $3.79B | +1 | — |
| Q3 2025 | 17 | 0 | 32.08M | $1.82B | — | −1 |
| Q2 2025 | 15 | +3 | 31.72M | $1.38B | +3 | — |
| Q1 2025 | 9 | -3 | 16.51M | $451.78M | — | −3 |
| Q4 2024 | 12 | +1 | 15.63M | $628.72M | +1 | — |
| Q3 2024 | 10 | 0 | 13.10M | $619.83M | +1 | −1 |
| Q2 2024 | 10 | — | 13.21M | $394.27M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 6.65M | +4.0% | $314.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 6.65M | +4.0% | $314.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.62M | +7.2% | $218.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.62M | +7.2% | $218.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.62M | +7.2% | $218.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.62M | +7.2% | $218.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 4.62M | +7.2% | $218.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 4.62M | +7.2% | $218.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 4.62M | +7.2% | $218.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passiv) | 1.05M | -0.1% | $49.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (passiv) | 1.05M | -0.1% | $49.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 270.04K | -22.6% | $12.78M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 188.20K | -36.3% | $8.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 188.20K | -36.3% | $8.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 117.68K | -68.8% | $5.57M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Norges Bank ✦ (passiv) | 91.23K | -22.6% | $4.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 61.33K | -60.1% | $2.90M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 61.33K | -60.1% | $2.90M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Millennium Management ✦ | 38.01K | +107.8% | $1.80M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 12.26K | Neu | $580,265 | 0.0% | New | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 12.26K | Neu | $580,265 | 0.0% | New | 1 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| AQR Capital Management | $580,265 | 0.0% |
| AQR Capital Management | $580,265 | 0.0% |
Ausgestiegen
| Renaissance Technologies | $4.27M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 254 Inhaber, 96.17M Anteile, $7.04B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.